Tarsus Pharmaceuticals Inc. closed an upsized $134.8 million public offering this month.The Irvine-based biopharmaceutical ...

Technology stocks are not in an artificial-intelligence-induced bubble and attractive investment opportunities in the sector ...

Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Gilead Sciences ...

Morgan Stanley is working with Goldman Sachs to explore the sale of its majority stake in German renewable project developer PNE, two people familiar with the matter said, a process that could trigger ...

Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they ...

Nightview Capital, an investment management company that concentrates exclusively on publicly traded equity strategies released its fourth quarter 2024 investor letter. A copy of the letter can be ...

The Goldman Sachs Group (NYSE:GS – Get Free Report) had its target price upped by investment analysts at JPMorgan Chase & Co.

Michael Hansen; Chief Financial Officer, Senior Vice President, Director; Cintas No 2 Corp George Tong; Analyst; The Goldman Sachs Group, Inc. Good day, everyone, and welcome to the Cintas Corporation ...

Presentation Operator Good day everyone and welcome to the Synthes Corporation Announces Fiscal 2025 Third Quarter Results ...

American companies are investing more in their future and getting a better return on their investments than overseas peers, ...

Analysts and recruiters predict that U.S. investment banks may reduce their workforce further if ongoing economic uncertainty continues to ...

U.S. investment banks are poised to cut more jobs if economic uncertainty continues to weigh on dealmaking in the months ...